Skip to main content

Genetics Startups

Updated July 2026

Companies in the genetics sector developing innovative solutions and technologies.

Explore 316 recently funded genetics companies with verified founder contact information and fundraising data.

Total Companies
316
Total Funding
$447.2M
Avg Funding
$17.9M
Global Reach
11
countries

Top Cities for Genetics

Milan
São Leopoldo
Hayward
New York
Boston
Barcelona

Recently Funded Companies

Export
Milan, Italy

GenoGra is a biotechnology company that specializes in genomic analysis using software tools and bioinformatics.

$1.2M raised
Feb 2026

Founder Contacts

30,000+ verified contacts

São Leopoldo, Brazil

We are decentralizing the clinical lab to deliver universal, lab-grade diagnostics, accelerating time-to-action by 100x.

$342K raised
Feb 2025

Founder Contacts

30,000+ verified contacts

Hayward, United States

Ocusphere Therapeutics Inc. is a biotech startup focused on gene therapy using non-viral vectors, targeting inherited retinal diseases.

$400K raised
Feb 2024

Founder Contacts

30,000+ verified contacts

New York, United States

Enabling Safer Gene Editing

$3.5M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Boston, United States

Liberate Bio develops non-viral delivery technologies for nucleic acid cargoes, aiming to address genetic disorders.

$31.0M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Boston, United States

Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.

$53.0M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

Barcelona, Spain

Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.

$3.2M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

New York, United States

Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.

$44.0M raised
Aug 2025

Founder Contacts

30,000+ verified contacts

Madison, United States

SpayVac for Wildlife is a biotechnology firm that produces vaccines for fertility control with a single injection for wildlife animals.

$1.0M raised
Jul 2025

Founder Contacts

30,000+ verified contacts

Fujisawa, Japan

Reborna Biosciences is a biotechnology firm offering research and development of RNA-targeting small molecule drugs for genetic diseases.

$5.3M raised
Jun 2025

Founder Contacts

30,000+ verified contacts

Cambridge, United Kingdom

OutSee creates cutting-edge computational methods for genomics for the development of therapeutic targets and precision medicine.

$2.4M raised
Jun 2025

Founder Contacts

30,000+ verified contacts

San Diego, United States

Actio Biosciences is a research center that develops drugs for rare diseases.

$66.0M raised
Jun 2025

Founder Contacts

30,000+ verified contacts

Newark, United States

Ace Vision Group develop laser-based therapeutic technologies to heal age-related eye dysfunction and restore the eye's natural performance.

$29.4M raised
Apr 2025

Founder Contacts

30,000+ verified contacts

Basel, Switzerland

XAI Platform for Cancer Genomics Interpretation SaaS

$1.9M raised
Apr 2025

Founder Contacts

30,000+ verified contacts

Bari, Italy

Digital biotech startup offers an ecosystem of AI-powered solutions for genetic analysis and clinical decision support for rare diseases

$4.9M raised
Apr 2025

Founder Contacts

30,000+ verified contacts

Montgomery, United States

Foment Bio is a clinical-stage biotechnology company developing non-viral, off-the-shelf, gene based products.

$543K raised
Mar 2025

Founder Contacts

30,000+ verified contacts

Emeryville, United States

Topaz Biosciences develops biological solutions leveraging microbial diversity for research and skin health.

$1.4M raised
Mar 2025

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Uncommon Therapeutics focuses on building drugs for rare diseases using cutting-edge technology.

$500K raised
Mar 2025

Founder Contacts

30,000+ verified contacts

Paris, France

EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.

$28.2M raised
Feb 2025

Founder Contacts

30,000+ verified contacts

Palo Alto, United States

I Peace is a technology company that provides research and development services for GMP products, drug discovery, and personal iPSC banking.

$9.7M raised
Feb 2025

Founder Contacts

30,000+ verified contacts

Reykjavík, Iceland

Arctic Therapeutics is a drug discovery and development company that focuses on identifying genetic causes of major diseases.

$27.5M raised
Jan 2025

Founder Contacts

30,000+ verified contacts

Saint Louis, United States

Geneoscopy develops a screening methodology to noninvasively diagnose colorectal cancer using biomarkers in stool samples.

$105.0M raised
Jan 2025

Founder Contacts

30,000+ verified contacts

Copenhagen, Denmark

Hervolution Therapeutics develops immunotherapies targeting tumors using Human Endogenous Retroviral proteins (HERVs).

$11.7M raised
Dec 2024

Founder Contacts

30,000+ verified contacts

Sunnyvale, United States

MiLaboratories is a biotech company developing leading software platform for immune repertoire profiling

$10.0M raised
Oct 2024

Founder Contacts

30,000+ verified contacts

Pohang, South Korea

Bio Design Lab is a biotechnology company that develops biopharmaceutical products.

$5.0M raised
Oct 2024

Founder Contacts

30,000+ verified contacts

Showing 176 to 200 of 316 companies

About the Genetics Startup Ecosystem

The genetics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Genetics

Genetics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The genetics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Genetics Funding Breakdown

Here is how funding is distributed among the 316 genetics companies tracked in the VCBacked database.

Average Funding
$17.9M
Total Funding Tracked
$447.2M
Countries Represented
11

Distribution by Funding Stage

Other25 companies

Top Cities for Genetics

1.New York
2 companies$47.5M
2.Boston
2 companies$84.0M
3.Milan
1 companies$1.2M
4.São Leopoldo
1 companies$342K
5.Hayward
1 companies$400K

Related Industries

Companies in the genetics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Genetics Startups?

Perfect for: B2B sales teams targeting genetics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

316 Genetics Startups (2026) — Recently Funded Companies, Investors & Rounds | VCBacked